Arlene Morris

Arlene Morris

Chairman chez TC BIOPHARM (HOLDINGS) PLC

Fortune : 36 615 $ au 31/03/2024

72 ans
Health Technology
Commercial Services
Consumer Services

Profil

Arlene M.
Morris
is currently the Chief Executive Officer at Willow Advisors LLC since 2015.
She is also the Chairman at TC Biopharm (Holdings) Plc since 2022.
Additionally, she holds the position of Independent Director at Palatin Technologies, Inc. since 2015, Viveve, Inc. since 2016, Cogent Biosciences, Inc. since 2019, Viridian Therapeutics, Inc. since 2018, and Director at Charleston Animal Society since 2022.
Previously, Ms. Morris served as the President, Chief Executive Officer & Director at Syndax Pharmaceuticals, Inc. from 2012 to 2015.
She held the same positions at Affymax, Inc. from 2003 to 2011 and Clearview Projects, Inc. from 2002 to 2004.
She was also the Chairman at Nuon Therapeutics, Inc. and an Independent Director at MediciNova, Inc. from 2011 to 2013.
Ms. Morris served as a Director at Biodel, Inc. from 2015 to 2016 and the Biotechnology Innovation Organization from 2006 to 2011.
She was a Director at the Humane Society of Silicon Valley from 2009 to 2011 and the Medical University of South Carolina Foundation.
She also served as an Independent Director at Dimension Therapeutics, Inc. from 2015 to 2018, Neovacs SA from 2011 to 2020, Neovacs, Inc. from 2011 to 2021, and Viveve Medical, Inc. from 2016 to 2022.
Ms. Morris held the position of Senior Vice President-Business Development at Coulter Pharmaceuticals, Inc. from 1996 to 2001, Scios, Inc. from 1993 to 1996, and Johnson & Johnson from 1977 to 1993.
Ms. Morris completed her undergraduate studies at Carlow College and Western New England University.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/09/2023 19 580 ( 0,12% ) 36 615 $ 31/03/2024
22/02/2024 0 ( -.--% ) - $ 31/03/2024
06/02/2024 0 ( -.--% ) - $ 30/11/2023
03/01/2023 3 ( 0,00% ) - $ 31/03/2024
14/06/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Arlene Morris

SociétésPosteDébut
PALATIN TECHNOLOGIES, INC. Director/Board Member 01/06/2015
VIRIDIAN THERAPEUTICS, INC. Director/Board Member 03/01/2018
COGENT BIOSCIENCES, INC. Director/Board Member 26/07/2019
TC BIOPHARM (HOLDINGS) PLC Chairman 14/02/2023
Director/Board Member 01/05/2016
Chief Executive Officer 01/05/2015
Director/Board Member 01/04/2022
Tous les postes actifs de Arlene Morris

Anciens postes connus de Arlene Morris

SociétésPosteFin
MUSC Foundation for Research Development Director/Board Member 01/07/2022
Carlow University Of Director/Board Member 01/03/2022
░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Arlene Morris

Formation de Arlene Morris

Carlow College Undergraduate Degree
Western New England University Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Arlene Morris

Relations

100 +

Relations au 1er degré

27

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées10
JOHNSON & JOHNSON

Health Technology

PALATIN TECHNOLOGIES, INC.

Health Technology

MEDICINOVA, INC.

Health Technology

SYNDAX PHARMACEUTICALS, INC.

Health Technology

COGENT BIOSCIENCES, INC.

Health Technology

AFFYMAX, INC.

Health Technology

NEOVACS

Health Technology

VIVEVE MEDICAL, INC.

Health Technology

VIRIDIAN THERAPEUTICS, INC.

Health Technology

TC BIOPHARM (HOLDINGS) PLC

Health Technology

Entreprise privées14

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

MUSC Foundation for Research Development

Health Technology

Commercial Services

Miscellaneous

Health Technology

Health Technology

Commercial Services

Commercial Services

Clearview Projects, Inc.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Arlene Morris